Use of ganglionic blockers to assess neurogenic pressor activity in conscious rats

Journal of Pharmacological and Toxicological Methods

Volumn 35, Issue 1, 1996, Pages 45-54

  Santajuliana, Daniel ^a   Hornfeldt, Barbara J ^a   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arterial pressure; Chlorisondamine; Hexamethonium; Neurogenic presser activity; Trimethaphan

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARGIPRESSIN; ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; CHLORISONDAMINE; GANGLION BLOCKING AGENT; HEXAMETHONIUM; LOSARTAN; TRIMETAPHAN; UNCLASSIFIED DRUG; VASOPRESSIN V1 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSOR RESPONSE; RAT; STANDARDIZATION; SYMPATHETIC TONE; TECHNIQUE;

EID: 0029937926     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8719(95)00132-8     Document Type: Article

References (34)

1. Abdel-Rahman A-RA (1989) Inadequate blockade by hexamethonium of the baroreceptor heart rate response in anesthetized and conscious rats. Arch Int Pharmacodyn 297:68-85.
2. Ando K, Ono A, Sato Y, Asano S, Fujita T (1994) Involvement of the sympathetic nervous system in antihypertensive effect of cicletanine in salt-loaded young spontaneously hypertensive rats. Am J Hypertens 7:550-554.
3. Applegate RJ, Hasser EM, Bishop VS (1987) Vagal cold block in area postrema-lesioned dogs: Interaction of vasopressin and sympathetic nervous system. Am J Physiol 252:H135-H141.
4. Aviado DM (1980) Pharmacology of Ganglionic Transmission. Berlin: Springer-Verlag.
5. Brooks VL, Osborn JW (1995) Hormonal-sympathetic interactions in long-term regulation of arterial pressure: An hypothesis. Am J Physiol 268:R1343-R1358.
6. Castro-Tavares J (1980) Direct effects of trimethaphan on the dog mesenteric artery and saphenous vein. Br J Anaesth 52:769-771.
7. Clarke PBS, Chaudieu I, El-Bizri H, Boksa P, Quik M, Esplin BA, Capek R (1994) The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br J Pharmacol 111:397-405.
8. El-Bizri H, Clarke PBS (1994) Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo. Br J Pharmacol 111:414-418.
9. Fadhel N, Seager LD (1969) The influence of hexamethonium intracisternally and of hexamethonium and trimethaphan camphorsulfonate intravenously on the pressor responses to intracisternal veratrine. Proc Soc Exp Biol Med 131:1263-1269.
10. Fahmy NR, Soter NA (1985) Effects of trimethaphan on arterial blood histamine and systemic hemodynamics in humans. Anesthesiology 62:562-566.
11. Ferguson AV, Smith P (1991) Autonomic mechanisms underlying area postrema stimulation-induced cardiovascular responses in rats. Am J Physiol 261:R1-R8.
12. Fink GD, Ploucha JM (1986) Contribution of the autonomic nervous system and vasopressin to elevated vascular resistance in the spontaneously hypertensive rat. J Hypertens 4(suppl 6):S594-S596.
13. Harioka T, Hatano T, Mori K, Toda N (1984) Trimethaphan is a direct arterial vasodilator and an alpha-adrenoceptor antagonist. Anesth Analg 63:290-296.
14. Huang BS, Huang X, Harmsen E, Leenen FHH (1994a) Chronic central versus peripheral ouabain, blood pressure and sympathetic activity in rats. Hypertension 23(pt. 2):1087-1090.
15. Huang M, Leblanc ML, Hester RL (1994b) Systemic and regional hemodynamics after nitric oxide synthase inhibition: Role of a neurogenic mechanism. Am J Physiol 267:R84-R88.
16. Ishikawa T, Funatsu N, Okamoto K, Takeshita H, McDowell DG (1982) Cerebral and systemic effects of hypotension induced by trimethaphan or nitroprusside in dogs. Acta Anaesthesiol Scand 26:643-648.
17. Kastrup J, Henriksen JH, Pedersen JH, Fahrekrug J, Schaffalitzky de Muckadell OB, Schwartz T, Parving HH, Christensen NJ (1986) Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patients. Clin Sci 71:411-419.
18. Kling Jr TF, Wilton N, Hensinger RN, Knight PR (1986) The influence of trimethaphan (Arfonad)-induced hypotension with and without spine distraction on canine spinal cord blood flow. Spine 11-3:219-224.
19. Knight PR, Lane GA, Hensinger RN, Bolles RS, Bjoraker DG (1983) Catecholamine and renin-angiotensin response during hypotensive anesthesia induced by sodium-nitroprusside or trimethaphan camsylate. Anesthesiology 59:248-253.
20. McCubbin JW, Page IH (1952) Nature of the hypotension action of a thiophanium derivative (RO 2-2222) in dogs. J Pharmacol Exp Ther 105:437-442.
21. Monk TG, Mueller M, White PF (1992) Treatment of stress response during balanced anesthesia. Anesthesiology 76:39-45.
22. Nakata T, Berard W, Kogosov E, Alexander N (1991) Hypothalamic norepinephrine release and cardiovascular response to NaCl in sinoaortic-denervated rats. Am J Physiol 260:R733-R738.
23. Nakazawa K, Taneyama C, Benson KT, Unruh GK, Goto H (1991) Mixtures of sodium nitroprusside and trimethaphan for induction of hypotension. Anesth Analg 73:59-63.
24. Nitter-Hauge S (1978) Circulatory effects of controlled arterial hypotension with trimethaphan (Arfonad). Br Heart J 40:401-405.
25. Osborn JW, Skelton MM, Cowley Jr AW (1987) Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats. Am J Physiol 252:H628-H637.
26. Pegoraro AA, Carretero OA, Sigmon DH, Beierwaltes WH (1992) Sympathetic modulation of endothelium-derived relaxing factor. Hypertension 19:643-647.
27. Saitoh N, Mikawa K, Kitamura S, Maekawa N, Goto R, Yaku H, Yamada M, Obara H (1991) Effects of trimethaphan on the cardiovascular response to tracheal intubation. Br J Anaesth 66: 340-344.
28. Salmoiraghi GC, McCubbin JW, Page IH (1957) Effect of d-lysergic acid diethylamine and its brom derivative on cardiovascular responses to serotonin and on arterial pressure. J Pharmacol Exp Ther 119:240-247.
29. Sato Y, Ando K, Fujita T (1987) Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats. Hypertension 9:81-87.
30. Scott DB, Stephen GW, Marshall RL, Jenkirison JL, MacRae WR (1972) Circulatory effects of controlled arterial hypotension with trimethaphan during nitrous oxide/halothane anaesthesia. J Anaesth 44:523-527.
31. Siedlecki J (1975) Disturbances in the function of cardiovascular system in patients following endotracheal intubation and attempts of their prevention by pharmacological blockade of sympathetic system. Anaesth Resuscit Intens Therapy 3:107-123.
32. Sury MRJ, Donaldson MDJ, Stringer M, Vesey CJ, Cole PV (1988) Cardiovascular actions of trimethaphan nitroprusside. Br J Anaesth 60:797-802.
33. Trostel KA, Osborn JW (1994) Does the spinal cord generate functionally significant sympathetic activity in the awake rat? Am J Physiol 266:R1102-R1110.
34. Wang HH, Liu LMP, Katz RL (1977) A comparison of the cardiovascular effects of sodium nitroprusside and trimethaphan. Anesthesiology 46:40-48.